Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

Trending

BIOTCHNO Trending 

MindMed’s LSD Neutralizer Study Begins

February 17, 2021April 30, 2021 Bachittar

Canada NewsWire Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, Switzerland, Feb. 17, 2021/CNW/ — MindMed (NEO: MMED), (OTCQB: MMEDF),

Read more
BIOTCHNO Trending 

The Valens Company Adds CBD 100 to Product Lineup Created for Medical Cannabis by Shoppers Inc.

February 11, 2021April 20, 2021 Bachittar

  Canada NewsWire KELOWNA, BC,Feb. 11, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a

Read more
BIOTCHNO Trending 

adMare BioInnovations Welcomes the First Quebec Start-Ups in its Accelerate Program

December 10, 2020April 20, 2021 vanessa

adMare today unveiled the six companies selected under its new acceleration program supported by the Quebec Government and the city of

Read more
BIOTCHNO Trending 

WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research

December 2, 2020April 14, 2021 vanessa

The company accelerated clients’ R&D and ensured agility by leveraging a global footprint, keen customer focus, and customized solutions. LONDON,

Read more

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057